Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mymd Pharmaceuticals Inc MYMD

Healthcare
MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. The Company’s MYMD-1 is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro... see more

Recent & Breaking News (NDAQ:MYMD)

AKER: Final Settlement Hearing Rescheduled to December 20, 2019

GlobeNewswire September 25, 2019

Akers Biosciences Reports Q2 2019 Earnings

GlobeNewswire August 15, 2019

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Akers Biosciences, Inc. Common Stock -- AKER

GlobeNewswire July 29, 2019

Akers Biosciences Reports Fiscal Year 2018 Earnings

GlobeNewswire April 1, 2019

The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial

Benzinga.com  December 21, 2018

The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas

Benzinga.com  December 19, 2018

Market Trends Toward New Normal in Gartner, CONVERGEONE HLD, Syros Pharmaceuticals, Akers Biosciences, Edge Therapeutics, and Cracker Barrel Old Country Store — Emerging Consolidated Expectations, Analyst Ratings

GlobeNewswire November 30, 2018

Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week

Benzinga.com  November 23, 2018

Overstock Could Sell Retail Unit As Soon As February Amid Blockchain Pivot

Benzinga.com  November 23, 2018

Mid-Afternoon Market Update: NASDAQ Down Over 3%; Spectrum Brands Shares Slide Following Downbeat Q4 Results

Benzinga.com  November 19, 2018

35 Stocks Moving In Monday's Mid-Day Session

Benzinga.com  November 19, 2018

Mid-Morning Market Update: Markets Open Lower; Cimarex Energy To Buy Resolute Energy For $1.6B

Benzinga.com  November 19, 2018

Akers Biosciences Exploring Potential Business Combinations in Alternative Sectors Including Cannabis Industry

GlobeNewswire November 19, 2018

45 Stocks Moving In Thursday's Mid-Day Session

Benzinga.com  November 15, 2018

Mid-Morning Market Update: Markets Open Lower; Walmart Profit Tops Expectations

Benzinga.com  November 15, 2018

Akers Biosciences Announces Q3 2018 Earnings

GlobeNewswire November 15, 2018

80 Biggest Movers From Yesterday

Benzinga.com  November 9, 2018

Akers Biosciences Announces Intention to Explore Strategic Alternatives to Maximize Shareholder Value

GlobeNewswire November 7, 2018

Market Trends Toward New Normal in PTC Therapeutics, AeroVironment, Autodesk, Coca-Cola Bottling Co. Consolidated, Akers Biosciences, and TEGNA — Emerging Consolidated Expectations, Analyst Ratings

GlobeNewswire October 23, 2018

Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update

GlobeNewswire October 8, 2018